Nomura Holdings Inc Pacira Bio Sciences, Inc. Transaction History

Nomura Holdings Inc

$41.1 Billion
Q3 2024

A detailed history of Nomura Holdings Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 89,998 shares of PCRX stock, worth $1.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,998

Previous 104,756 14.09%

Holding current value

$1.75 Million

Previous $3 Million 54.79%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $172,668 - $420,012	-14,758 Reduced 14.09%	89,998 $1.36 Million
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $2.43 Million - $3 Million	95,283 Added 1005.84%	104,756 $3 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $262,402 - $336,102	9,473 New	9,473 $276,000
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $664,816 - $866,636	25,259 New	25,259 $852,000
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $245,714 - $369,633	6,434 New	6,434 $248,000
Q1 2022 May 18, 2022	SELL	$60.03 - $76.49 $50,905 - $64,863	-848 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $199,411 - $258,606	-4,157 Reduced 83.06%	848 $51,000
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $514,326 - $577,016	-9,413 Reduced 65.29%	5,005 $285,000
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $2.05 Million - $2.42 Million	-34,581 Reduced 70.57%	14,418 $876,000
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $2.62 Million - $3.48 Million	44,214 Added 924.01%	48,999 $3.44 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $364,141 - $478,065	-7,215 Reduced 60.12%	4,785 $286,000
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $623,640 - $756,000	12,000 New	12,000 $721,000
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $187,726 - $319,804	-6,095 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $173,098 - $309,016	6,095 New	6,095 $204,000
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $634,512 - $1.13 Million	-22,342 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $15,722 - $20,277	-433 Reduced 1.9%	22,342 $1.01 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $847,103 - $1.07 Million	-23,755 Reduced 51.05%	22,775 $840,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $4,351 - $5,708	119 Added 0.26%	46,530 $1.98 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $468,201 - $541,378	12,838 Added 38.24%	46,411 $1.74 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $973,800 - $1.23 Million	23,573 Added 235.73%	33,573 $1.44 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $328,500 - $520,000	10,000 New	10,000 $478,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Pacira Bio Sciences, Inc. Transaction History